Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cancers|February 26, 2025
Recent Anti-KRASG12D Therapies: A "Possible Impossibility" for Pancreatic Ductal AdenocarcinomaNavid Sobhani, Matteo Pittacolo, Alberto D'Angelo, et al.
International Immunopharmacology|November 4, 2021
Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospectsRaheleh Roudi, Alberto D'Angelo, Marianna Sirico, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|March 8, 2025
CD47 as a potent target in cancer immunotherapy: A reviewHiva Ahvati, Raheleh Roudi, Navid Sobhani, et al.
Computational Biology and Chemistry|January 3, 2025
Investigation of mesenchymal stem cell secretome on breast cancer gene expression: A bioinformatic approach to identify differentially expressed genes, functional networks, and potential therapeutic targetsMohammad Rasouli, Fatemeh Safari, Raheleh Roudi, et al.
Cancers|August 7, 2020
MR1-Restricted T Cells in Cancer ImmunotherapyPedro Flores-Villanueva, Navid Sobhani, Xu Wang, et al.
International Journal of Clinical Oncology|November 10, 2019
Corticosteroid switch after progression on abiraterone acetate plus prednisoneGiandomenico Roviello, Navid Sobhani, Silvia Paola Corona, et al.
Genes & Cancer|July 7, 2017
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesotheliomaNavid Sobhani, Silvia P Corona, Fabrizio Zanconati, et al.
World Journal of Clinical Oncology|August 22, 2020
Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancerNavid Sobhani, Marianna Sirico, Daniele Generali, et al.
World Journal of Clinical Oncology|April 14, 2018
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Navid Sobhani, Daniele Generali, Fabrizio Zanconati, et al.
Molecular and Cellular Biochemistry|February 8, 2025
Current understanding of PEAK family members in regulation of cellular signaling pathways and cancer therapyMana Alavi, Raheleh Roudi, Alberto D'Angelo, et al.
Pageof 6